ReviewAnnals of surgical oncology2025
Challenges, Treatment Strategies, and Surgical Techniques in the Management of Spermatic Cord Sarcomas.
Review in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Paratesticular epithelioid sarcoma in a pediatric patient.Urology case reports · 2026Article
- Spermatic cord liposarcoma mimicking recurrent incarcerated inguinal hernia: A case report.Urology case reports · 2026Article
- Multidisciplinary Treatment of Inguinoscrotal Sarcomas: Analysis of 39 Cases Treated by Surgical Approach.Cancers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spermatic cord sarcomas (SCS) are a group of mesenchymal tumors whose rarity and anatomical location often lead to clinical misdiagnosis such as inguinal hernia, testicular tumor, or other conditions. Any inguinoscrotal mass with suspicious characteristics should prompt clinicians to perform imaging assessments (such as ultrasound or, in uncertain cases, magnetic resonance imaging (MRI)) and refer the patient promptly to a specialized center. Histological characterization of all suspicious masses via percutaneous biopsy is recommended, with staging completed through computed tomography (CT) scan for confirmed cases. Optimal management is multidisciplinary and should consider both the tumor's histological subtype and specific characteristics of the tumor and patient. Radiotherapy and chemotherapy, while awaiting more robust data in the literature, are valuable adjuncts to surgery, which remains the cornerstone of treatment. Surgery should also be proposed for patients who initially underwent nonspecialist procedures, as a completion approach. The surgical strategy involves en bloc resection through radical orchifunicolectomy, ipsilateral hemiscrotectomy, ligation of the spermatic cord at the internal inguinal ring, and, where necessary, resection of the inguinal canal. Reconstruction may employ mesh or pedicled flaps. The prognosis of SCS, when treated at referral centers, is superior to that of mesenchymal tumors at other sites, underscoring the need for early recognition and prompt multidisciplinary care.
Indexed as
Identifiers
39719513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.